Telormedix SA

Via della Posta 10
6934 Bioggio
Switzerland

Contact

About Telormedix

Telormedix is a clinical stage biopharmaceutical company founded in 2008 and focused on targeted immunity in the treatment of cancer and other diseases. Located in Switzerland, Telormedix is led by a highly experienced management team and backed by a consortium of leading global investors.

Product portfolio of Telormedix

Product portfolio

Show all

News about Telormedix

03-Aug-2011 | people

Telormedix Appoints Nick Rogerson as New Chairman of the Board

Telormedix announced the appointment of Nicholas Ralphe Rogerson as the Company’s Chairman of the Board.Nicholas Rogerson has worked in the pharmaceutical ...

Read news

16-Jun-2010 | research and development

Telormedix’ TMX-101 Commences Clinical Trial for Bladder Cancer

Telormedix announced the start of a Phase I/II clinical study of TMX-101 for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). TMX-101 is an ...

Read news

06-May-2010 | people

Telormedix Appoints Chief Financial Officer

Telormedix announced that it has appointed Phillipe Lutz as its new Chief Financial Officer. Lutz joins Telormedix from Synosia Therapeutics where he has ...

Read news

29-Oct-2009 | people

Telormedix Appoints Johanna Holldack as CEO

Telormedix announced that it has appointed Dr. Johanna Holldack as its new Chief Executive Officer. Dr. Holldack was previously Chief Executive Officer of ...

Read news

Show more news about Telormedix

Get the life science industry in your inbox

Telormedix SA

About Telormedix

Product portfolio of Telormedix

Product portfolio

News about Telormedix

Telormedix Appoints Nick Rogerson as New Chairman of the Board

Telormedix’ TMX-101 Commences Clinical Trial for Bladder Cancer

Telormedix Appoints Chief Financial Officer

Telormedix Appoints Johanna Holldack as CEO

Here you will find Telormedix SA

Telormedix SA